Novo Nordisk Investigational Site

Baton Rouge, Louisiana 70809

0 studies enrolling now · 12 studies all time

What they study most

Chronic Kidney Disease, Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, End-Stage Renal Disease, Metabolism and Nutrition Disorder, Obesity, Overweight

Studies at this site

• Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity — Completed
• Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus — Completed
• Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity — Completed
• Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity — Completed
• Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes — Stopped early
• Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes — Completed
• The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis — Stopped early
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes — Completed
• Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes — Completed
• Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes — Completed
• Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population — Completed
• Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents — Completed